Medicine and Dentistry
Cardiac Troponin
100%
Randomized Controlled Trial
100%
Myocardial Infarction
94%
Troponin
66%
Acute Coronary Syndrome
66%
Intensive Care
50%
Intensive Care Unit
50%
Randomized Clinical Trial
50%
Aortic Stenosis
50%
Early Intervention
50%
Cardiac Fibrosis
50%
Troponin I
47%
Odds Ratio
27%
Analgesia
25%
Cardiovascular System
22%
Hazard Ratio
16%
Conservative Treatment
16%
Emergency Department
13%
Aortic Valve
11%
Heart Muscle Injury
11%
Attributable Risk
8%
Heart Death
8%
Deep Sedation
8%
Emergency Care
8%
Nurse
8%
Behavioral Change
8%
Delirium
8%
All Cause Mortality
8%
Quality Improvement
8%
Health Care Provider
8%
Physiotherapist
8%
Decision Making
8%
Aortic Valve Replacement
5%
New York Heart Association Class
5%
Intention-to-Treat Analysis
5%
Tertiary Care
5%
Secondary Care
5%
Mixed Model
5%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Heart Infarction
100%
Troponin
100%
Acute Coronary Syndrome
66%
Troponin I
52%
Heart Muscle Fibrosis
50%
Aortic Stenosis
50%
Randomized Clinical Trial
50%
Bisphosphonic Acid Derivative
50%
Placebo
50%
Alendronic Acid
50%
Fracture Healing
50%
Heart Muscle Injury
12%
Distal Radius Fracture
12%
Fracture Nonunion
12%
Heart Death
8%
All Cause Mortality
8%
Mixed Model
6%
Nursing and Health Professions
Troponin
50%
Heart Infarction
50%
Acute Coronary Syndrome
50%
Intensive Care Unit
50%
Sedation
50%
Intensive Care
50%
Troponin I
43%
Practice Guideline
15%
Analgesia
15%
Heart Muscle Injury
12%
Clinical Outcome
6%
Odds Ratio
6%
Secondary Care Center
6%
Tertiary Care Center
6%
Total Quality Management
5%
Thematic Analysis
5%
Deep Sedation
5%
Delirium
5%
Treatment Outcome
5%
Professional Standard
5%
Physiotherapist
5%
